Ca2+-permeable channel TRPV2 as a promising therapeutic target for muscular dystrophy and cardiomyopathy

被引：0
|
作者：
Iwata, Y. [1 ]
Wakabayashi, S. [1 ]
机构：
[1] Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 565, Japan
来源：
NEUROMUSCULAR DISORDERS | 2010年 / 20卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2010.07.181
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：653 / 653
页数：1
相关论文
共 50 条
  • [1] Amelioration of muscular dystrophy by dominant-negative inhibition of Ca2+ permeable channel TRPV2
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 96P - 96P
  • [2] Development of Ca2+ permeable channel (TRPV2) inhibitors potentially available for therapy of muscular dystrophy
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 165P - 165P
  • [3] Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
    Iwata, Yuko
    Matsumura, Tsuyoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
  • [4] TRPV2 inhibition therapy can be effective for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 423 - 423
  • [5] TRPV2 inhibition therapy can be effective for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S204 - S205
  • [6] Inhibition of Ca2+ permeable channel TRPV2 activity ameliorates muscular dysgenesis in cardiomyopathic animal models
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 127P - 127P
  • [7] Mechanosensitive Ca2+-permeable channels in human leukemic cells: Pharmacological and molecular evidence for TRPV2
    Pottosin, Igor
    Delgado-Enciso, Ivan
    Bonales-Alatorre, Edgar
    Nieto-Pescador, Maria G.
    Moreno-Galindo, Eloy G.
    Dobrovinskaya, Oxana
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (01): : 51 - 59
  • [8] Long-term effects of TRPV2 inhibition therapy for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 817 - 817
  • [9] Long-term effects of TRPV2 inhibition therapy for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S114 - S114
  • [10] AMELIORATION OF MUSCULAR DYSTROPHY BY DOMINANT-NEGATIVE INHIBITION OF Ca2+ INFLUX VIA TRPV2
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 397 - 397
12345